HealthEquity (NASDAQ:HQY) Price Target Increased to $85.00 by Analysts at Barrington Research

HealthEquity (NASDAQ:HQY) had its target price lifted by Barrington Research from $80.00 to $85.00 in a report released on Wednesday, MarketBeat.com reports. They currently have an outperform rating on the stock.

A number of other analysts have also recently issued reports on the stock. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of HealthEquity from $69.00 to $71.00 in a research note on Wednesday, June 7th. Royal Bank of Canada boosted their price objective on shares of HealthEquity from $75.00 to $77.00 and gave the stock an outperform rating in a research note on Wednesday. Finally, StockNews.com started coverage on shares of HealthEquity in a research note on Thursday, August 17th. They issued a hold rating for the company. Three analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of Moderate Buy and a consensus price target of $82.80.

HealthEquity Stock Performance

Shares of HQY opened at $69.35 on Wednesday. The company’s 50 day moving average price is $65.95 and its 200 day moving average price is $61.41. HealthEquity has a 52 week low of $48.86 and a 52 week high of $79.20. The company has a market capitalization of $5.93 billion, a PE ratio of -693.50, a PEG ratio of 2.53 and a beta of 0.79. The company has a debt-to-equity ratio of 0.45, a quick ratio of 4.00 and a current ratio of 4.00.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Monday, June 5th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.23 by $0.09. The firm had revenue of $244.43 million during the quarter, compared to analysts’ expectations of $239.85 million. HealthEquity had a negative net margin of 0.93% and a positive return on equity of 4.30%. Research analysts expect that HealthEquity will post 1.2 EPS for the current fiscal year.

Insider Activity at HealthEquity

In other HealthEquity news, EVP Elimelech Rosner sold 10,156 shares of the business’s stock in a transaction on Monday, June 12th. The shares were sold at an average price of $64.29, for a total value of $652,929.24. Following the sale, the executive vice president now owns 70,334 shares of the company’s stock, valued at approximately $4,521,772.86. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other HealthEquity news, EVP Elimelech Rosner sold 10,156 shares of the business’s stock in a transaction on Monday, June 12th. The shares were sold at an average price of $64.29, for a total value of $652,929.24. Following the sale, the executive vice president now owns 70,334 shares of the company’s stock, valued at approximately $4,521,772.86. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Jon Kessler sold 19,588 shares of the business’s stock in a transaction on Monday, June 26th. The shares were sold at an average price of $60.12, for a total transaction of $1,177,630.56. Following the completion of the sale, the chief executive officer now directly owns 6,129 shares in the company, valued at approximately $368,475.48. The disclosure for this sale can be found here. Corporate insiders own 2.70% of the company’s stock.

Institutional Investors Weigh In On HealthEquity

Several institutional investors and hedge funds have recently bought and sold shares of the business. O Shaughnessy Asset Management LLC grew its holdings in shares of HealthEquity by 3.3% in the 2nd quarter. O Shaughnessy Asset Management LLC now owns 5,060 shares of the company’s stock worth $319,000 after purchasing an additional 160 shares during the last quarter. Rockefeller Capital Management L.P. grew its holdings in shares of HealthEquity by 2.2% in the 4th quarter. Rockefeller Capital Management L.P. now owns 7,727 shares of the company’s stock worth $476,000 after purchasing an additional 167 shares during the last quarter. Metropolitan Life Insurance Co. NY grew its holdings in shares of HealthEquity by 3.6% in the 4th quarter. Metropolitan Life Insurance Co. NY now owns 5,190 shares of the company’s stock worth $320,000 after purchasing an additional 179 shares during the last quarter. Institute for Wealth Management LLC. grew its holdings in shares of HealthEquity by 2.7% in the 2nd quarter. Institute for Wealth Management LLC. now owns 6,843 shares of the company’s stock worth $432,000 after purchasing an additional 179 shares during the last quarter. Finally, Metropolitan Life Insurance Co NY grew its holdings in shares of HealthEquity by 3.6% in the 4th quarter. Metropolitan Life Insurance Co NY now owns 5,190 shares of the company’s stock worth $320,000 after purchasing an additional 179 shares during the last quarter. Institutional investors own 98.46% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.